ONCAlert | 2017 San Antonio Breast Cancer Symposium
View all HER2- Breast Cancer

HER2- Breast Cancer: Videos

5-Year Follow-Up of CALGB 40502 Study in TNBC
5-Year Follow-Up of CALGB 40502 Study in TNBC
Overcoming Resistance in ER+ Breast Cancer
Overcoming Resistance in ER+ Breast Cancer
APHINITY Trial for HER2+ Breast Cancer
APHINITY Trial for HER2+ Breast Cancer
Use of HER2-Targeted Therapy in Breast Cancer
Use of HER2-Targeted Therapy in Breast Cancer
The Prevalence of Brain Metastases in TNBC
The Prevalence of Brain Metastases in TNBC
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.